FMR CORP 13D and 13G filings for Sage Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-07 10:01 am Sale |
2025-02-28 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 500,915 0.800% |
-3,616,090 (-87.83%) |
Filing |
| 2025-02-12 09:30 am Sale |
2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 4,117,006 6.700% |
-1,154,102 (-21.89%) |
Filing |
| 2024-11-12 10:34 am Sale |
2024-11-08 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 5,271,108 8.634% |
-1,031,366 (-16.36%) |
Filing |
| 2024-06-10 09:48 am Purchase |
2024-06-07 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 6,302,474 10.472% |
819,997 (+14.96%) |
Filing |
| 2024-02-09 09:49 am Sale |
2024-02-08 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 5,482,477 9.132% |
-1,069,013 (-16.32%) |
Filing |
| 2023-02-09 12:31 pm Purchase |
2023-02-09 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 6,551,490 11.012% |
574,397 (+9.61%) |
Filing |
| 2022-07-11 08:49 am Purchase |
2022-07-08 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 5,977,093 10.119% |
486,519 (+8.86%) |
Filing |
| 2022-02-09 10:24 am Sale |
2022-02-08 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 5,490,574 9.320% |
-188,697 (-3.32%) |
Filing |
| 2021-08-10 10:33 am Sale |
2021-08-09 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 5,679,271 9.711% |
-2,127,428 (-27.25%) |
Filing |
| 2021-02-08 10:31 am Purchase |
2021-02-05 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 7,806,699 14.999% |
34,070 (+0.44%) |
Filing |